Topics

KOL Perspectives: Treatment strategies for pregnant RA patients [Report Updated: 23072018] Prices from USD $2125

04:41 EST 29 Nov 2018 | BioPortfolio Report Blog

KOL Perspectives: Treatment strategies for pregnant RA patients


Summary


This KOL Insight briefing focuses on KOLs views of Treatment strategies for pregnant RA patients.


Questions topics

Current views on suitable therapies to treat pregnant RA patients

Certolizumab use in pregnant RA patients

Other antiTNFs use in pregnant RA patients

IL6 inhibitors use in pregnant RA patients

Abatacept use in pregnant RA patients

JAK inhibitors use in pregnant RA patients


Key Highlights


Majority of KOLs currently use antiTNFs for treating pregnant RA patients, with a marked preference for certolizumab

No consensus among KOLs on the use of IL6 inhibitors during pregnancy, although monotherapy use was not considered an advantage

Majority of KOLs were averse to prescribing JAK inhibitors during pregnancy, primarily due to the lack of any data in this setting.


Scope


The insight briefing is based on Sociable Pharma's analysis of primary research with our RA key opinion leaders KOLs.


In total, we conducted interviews with 10 KOLs

5 Europebased 5 N. Americabased

Interviews performed during Apr 2018


KOL data is analyzed to produce

Charts summarizing KOL opinions

Chart callouts of key information details

KOL quotes

Summary of KOL reporting trends

Insight from Sociable Pharma's analysts


Reasons to buy


Combines Qualitative semiquantitative insight from key opinion leaders on Treatment strategies for pregnant RA patients

Includes insight recommendations from our diseasespecific healthcare analysts

Utilizes independent expert viewpoints to validate the impact of new clinical data emerging trends on management of RA

Provides costeffective support for your advisory boards, with topics acting as a catalyst for further expert discussion.

Original Article: KOL Perspectives: Treatment strategies for pregnant RA patients [Report Updated: 23072018] Prices from USD $2125

NEXT ARTICLE

More From BioPortfolio on "KOL Perspectives: Treatment strategies for pregnant RA patients [Report Updated: 23072018] Prices from USD $2125"

Quick Search

Relevant Topic

Obstetrics and gynaecology
Fertility Menopause Obstetrics & Gynaecology Osteoporosis Women's Health Obstetrics and gynaecology comprises the care of the pregnant woman, her unborn child and the management of diseases specific to women. Most consultant...